Dachaigh › Aillse colorectal › Pennsylvania › Philadelphia
Sgrùdaidhean clionaigeach Aillse colorectal ann an Philadelphia, PA
Tha 44 sgrùdaidhean airson Aillse colorectal a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
A’ fastadhÌre 2
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mìle air falbh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mìle air falbh
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A’ fastadhÌre 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Alliance Cancer Specialists at Main Line, Penn Wynne · 6 mìle air falbh
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- GSK Investigational Site, Philadelphia
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
A’ fastadhÌre 1
- Research Site, Philadelphia
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A’ fastadhÌre 3
- Thomas Jefferson University, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
A’ fastadhÌre 3
- Fox Chase Cancer Center, Philadelphia
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A’ fastadhÌre 1/2
- Hospital of the University of Pennsylvania, Philadelphia
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A’ fastadhÌre 3
- University of Pennsylvania, Philadelphia
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A’ fastadhÌre 3
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
- Clinical Study Site, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
A’ fastadhÌre 2
- Thomas Jefferson University - Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
- Children's Hospital of Philadelphia, Philadelphia
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
A’ fastadhSgrùdadh amharc
- University of Pennsylvania, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
TCR1188-ABC Cells in KRAS-mutated Cancers
A’ fastadhÌre 1
- University of Pennsylvania, Philadelphia
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- Thomas Jefferson University, Philadelphia
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania, Philadelphia
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
A’ fastadhÌre 1
- Jefferson University Hospitals, Philadelphia
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
A’ fastadhÌre 2
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
A’ fastadhÌre 2
- Abramson Cancer Center at the University of Pennsylvania /ID# 275407, Philadelphia
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A’ fastadhÌre 4
- Jefferson Health, Philadelphia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
A’ fastadhÌre 1
- Sidney Kimmel Cancer Center, Philadelphia
CT-95 in Advanced Cancers Associated With Mesothelin Expression
A’ fastadhÌre 1
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
A’ fastadhÌre 2
- Alliance Cancer Specialists, Wynnewood · 7 mìle air falbh
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
A’ fastadhÌre 1/2
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas
A’ fastadhÌre 1
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1
- Sydney Kimmel Cancer Center, Philadelphia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
A’ fastadhÌre 1/2
- Univ of Pennsylvania, Abramson Cancer Center, Philadelphia
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mìle air falbh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
A’ fastadhÌre 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- University of Pennsylvania, Philadelphia
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
A’ fastadhÌre 1/2
- University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
A’ fastadhÌre 4
- Albert Einstein Healthcare Network, Philadelphia
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
A’ fastadhSgrùdadh amharc
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
A’ fastadhSgrùdadh amharc
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mìle air falbh
Collection of Samples USOPTIVAL Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- University of Pennsylvania, Philadelphia
Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
A’ fastadhÌre 1 tràth
- Fox Chase Cancer Center, Philadelphia
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
A’ fastadhÌre 3
- Perelman Center for Advanced Medicine, Philadelphia
Sgrùdaidhean Aillse colorectal ann am bailtean eile
- Houston, TX102 sgrùdaidhean
- New York City, NY78 sgrùdaidhean
- Nashville, TN69 sgrùdaidhean
- Boston, MA63 sgrùdaidhean
- Los Angeles, CA59 sgrùdaidhean
- Arlington, VA52 sgrùdaidhean
- St. Louis, MO50 sgrùdaidhean
- San Antonio, TX46 sgrùdaidhean
- Grand Rapids, MI40 sgrùdaidhean
- Baldwin Park, CA37 sgrùdaidhean
- Chicago, IL34 sgrùdaidhean
- Tampa, FL34 sgrùdaidhean
Sgrùdaidhean eile ann an Philadelphia
- Aillse (gach seòrsa)59 sgrùdaidhean
- Aillse a' bhroilleach56 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag51 sgrùdaidhean
- Ailse metastatach46 sgrùdaidhean
- Aillse Prostata44 sgrùdaidhean
- Cancer Ovarian44 sgrùdaidhean
- Ailseachadh nan Sgamhan36 sgrùdaidhean
- Leukemia myeloid geur34 sgrùdaidhean
- Fàilligeadh a' Chridhe31 sgrùdaidhean
- Ailse Endometrial28 sgrùdaidhean
- Depression26 sgrùdaidhean
- Cancer Pancreatic26 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.